Second-generation antipsychotics: looking beyond efficacy

Editorial

A George Awad. Can J Psychiatry. 2004 May.

. 2004 May;49(5):283-4.

doi: 10.1177/070674370404900501.

No abstract available

Comment on

Is neuroleptic dysphoria a variant of drug-induced extrapyramidal side effects?
Voruganti LP, Awad AG. Voruganti LP, et al. Can J Psychiatry. 2004 May;49(5):285-9. doi: 10.1177/070674370404900502. Can J Psychiatry. 2004. PMID: 15198463 Review.
Subjective experience and dopamine D2 receptor occupancy in patients treated with antipsychotics: clinical implications.
de Haan L, Lavalaye J, van Bruggen M, van Nimwegen L, Booij J, van Amelsvoort T, Linszen D. de Haan L, et al. Can J Psychiatry. 2004 May;49(5):290-6. doi: 10.1177/070674370404900503. Can J Psychiatry. 2004. PMID: 15198464 Review.
New antipsychotics, compliance, quality of life, and subjective tolerability--are patients better off?
Awad AG, Voruganti LN. Awad AG, et al. Can J Psychiatry. 2004 May;49(5):297-302. doi: 10.1177/070674370404900504. Can J Psychiatry. 2004. PMID: 15198465 Review.